Open Medicine AI

Open Medicine AI is a precision medicine company dedicated to transforming the diagnosis and treatment of complex chronic diseases, including ME/CFS, Long COVID, and fibromyalgia. The company leverages advanced artificial intelligence and machine learning to analyze multi-omic data, clinical records, and patient-reported outcomes to identify biomarkers and therapeutic targets. By integrating deep phenotyping with computational modeling, Open Medicine AI aims to provide personalized insights for patients and clinicians while accelerating drug discovery for underserved populations. Their platform serves as a bridge between clinical care and large-scale research, focusing on conditions that have historically lacked clear diagnostic pathways. Through strategic partnerships and data-driven insights, the company seeks to validate new treatments and improve the quality of life for millions of patients worldwide.